Prentiss Smith & CO Inc Stryker Corp Transaction History

Prentiss Smith & CO Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Jun 21, 2021	SELL	$221.01 - $248.82 $198,909 - $223,938	-900 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$202.01 - $245.04 $181,809 - $220,536	900 New	900 $221,000
Q4 2018 Jan 15, 2019	SELL	$145.0 - $178.65 $131,515 - $162,035	-907 Closed	0 $0
Q2 2018 Jul 19, 2018	SELL	$155.17 - $179.78 $253,858 - $294,120	-1,636 Reduced 64.33%	907 $153,000
Q1 2018 Apr 20, 2018	SELL	$148.01 - $168.91 $312,005 - $356,062	-2,108 Reduced 45.32%	2,543 $409,000
Q4 2017 Feb 13, 2018	SELL	$143.51 - $159.74 $36,882 - $41,053	-257 Reduced 5.24%	4,651 $720,000
Q3 2017 Oct 23, 2017	BUY	$138.36 - $147.87 $679,070 - $725,745	4,908	4,908 $697,000

2,232

284M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $138B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Prentiss Smith & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Prentiss Smith & CO Inc with notifications on news.